USA Equities Corp. Announces Third Quarter 2021 Financial Results And Conversion of Secured Convertible Promissory Note

NEXT STORY
Takeda’s Area Offices in Dubai, United Arab Emirates Certified Sustainable and Inaugurated
PREV STORY
Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy of Ophthalmology 2021 and American Uveitis Society Meetings
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Teladoc Announces Proposed Sale of Shares of Common Stock

PURCHASE, NY, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC) (“Teladoc”) today announced a ...

author_avatar
NASDAQ Market News

EUROPEAN  COMMISSION  GRANTS  MARKETING  AUTHORIZATION FOR JYSELECA® (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS  WITH  MODERATE  TO  SEVERE ACTIVE  RHEUMATHOID  ARTHRITIS

author_avatar
NASDAQ Market News

G1 Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for COSELA™ (Trilaciclib) in Combination with Chemotherapy for the Treatment of Locally Advanced or Metastatic Triple Negative Breast Cancer

author_avatar
NASDAQ Market News